🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Carlos Herrera-Montávez

Fox Chase Cancer Center

ORCID: 0000-0001-8586-7778
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.

31 citations

Carlos Herrera-Montávez, Jennifer Brown, Katherine J. Johnson, Valerie L. Sodi, Nishi Srivastava +12 more

12 citations

Carlos Herrera-Montávez, Sara Montserrat, Daniela Araiza, Jianping Hu, Jian Jin +2 more

111 citations

Carlos Herrera-Montávez, Sara Montserrat‐Sangrà, Daniela Araiza‐Olivera, Jianping Hu, Ryan Neumann-Domer +6 more

1 citations

Alison Kurimchak, Carlos Herrera-Montávez, Glenn A. Doyle, Brandon D. Fox, Ishadi K. M. Kodikara +5 more

0 citations

Claude Shelton, Carlos Herrera-Montávez, Kelly E. Duncan, Jonathan Chernoff, James S. Duncan +1 more